Recap: United Therapeutics Q3 Earnings

United Therapeutics UTHR reported its Q3 earnings results on Wednesday, November 3, 2021 at 08:00 AM.

Here's what investors need to know about the announcement.

United Therapeutics their estimated earnings by 15.88%, reporting an EPS of $4.16 versus an estimate of $3.59, which surprised analysts.

Revenue was up $64,600,000 from the same period last year.

Last quarter the company beat on EPS by $1.07, which was followed by a 0.33% drop in the share price the next day.

Here's a look at United Therapeutics's past performance:

Quarter	Q2 2021	Q1 2021	Q4 2020	Q3 2020
EPS Estimate	3.02	2.94	3.14	2.78
EPS Actual	4.09	3.49	3.31	3.88
Revenue Estimate	378.75M	368.95M	361.07M	356.95M
Revenue Actual	446.50M	379.10M	384.90M	380.10M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

Overview Rating:

Good

100

0100

Earnings Calendar